Impact of Probiotics on Gut Microbiome During Antibiotic Prophylaxis in Elective Orthopedic Surgery

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAcibadem Maslak Hospital

About this trial

This study aims to evaluate whether probiotics can help maintain a healthy gut microbiome in patients receiving prophylactic antibiotics during elective orthopedic surgery. Antibiotics, while effective in preventing infections, can disrupt the balance of gut bacteria, leading to dysbiosis. The study hypothesizes that the use of probiotics during the perioperative period can prevent or reduce this disruption, supporting gut health and overall well-being. The research seeks to answer whether combining probiotics with routine antibiotic prophylaxis can preserve gut microbiome balance and improve patient outcomes.

Eligibility criteria

Qualifiers

Adults aged between 18 and 65 years

Scheduled for elective low-risk orthopedic surgery (carpal tunnel release, A1 pulley release, knee arthroscopic surgery).

Disqualifiers

History of infection or antibiotic use within the last 12 weeks.

Use of routine probiotics, vitamins, or herbal supplements in the last 4 weeks.

Known allergy to beta-lactam or cephalosporin antibiotics.

History of autoimmune disease, uncontrolled systemic disease, or chronic inflammatory conditions (e.g., systemic lupus erythematosus, rheumatoid arthritis).

Trial design

Treatments tested in this trial

  • Placebo Capsule
  • Probiotic with Human Milk Oligosaccharides (HMO)

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Acibadem Maslak Hospital

Lead sponsor

Acibadem University

Collaborator